Outcomes Rocket · 2026-06-23 · 12 min
AI in medtech is most valuable when it supports better clinical decisions, not when it replaces clinicians. In this episode, Alexis Anderson speaks with Will Mauldin, Co-Founder and CEO of Rivanna Medical, live from DeviceTalks Boston. Will explains how Rivanna is bringing AI-enabled imaging to clinical settings where providers have traditionally relied on blind or manual procedures, beginning with epidural anesthesia guidance and expanding into fracture detection. He shares how the company’s handheld spine guidance technology helps clinicians visualize the epidural space, use AI as a confirmation tool, and build confidence through consistent outcomes. Will also discusses broader medtech trends around AI, automation, connected devices, and robotics, along with funding challenges for mid-stage companies and Rivanna’s upcoming FDA milestones. Tune in and learn how AI-enabled imaging can improve safety, reduce bottlenecks, and support clinicians in high-demand care environments. Resources Connect and follow Will Mauldin on LinkedIn. Follow Rivanna Medical on LinkedIn and explore their website.
Why Customer Success Is the Next Major Category in MedTech with Rupal Ayer, Senior Director of Customer Success at Solventum63 / 100
Closing the Treatment Gap for Patients Living with Tremor with Deanna Harshbarger, CEO of Cala Health
Changing the Clinical Value Equation in Orthopedic Care with Nic Aldrich, Vice President of Marketing at OrthAlign
From Blind Biopsies to Precision: Reinventing Medical Imaging with Reza Khorasaninejad, Founder & CEO at LEADOPTIK
Building Bridges Across the Healthcare Ecosystem with Adam McMullin, CEO of AvaSure